The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Six-transmembrane epithelial antigen of the prostate 1 protects against increased oxidative stress via a nuclear erythroid 2-related factor pathway in colorectal cancer
Abstract
The over-expression of six-transmembrane epithelial antigen of the prostate 1 (STEAP1) underlies the pathogenesis of a large subset of human cancers. Expressed on the cancer cell surface, STEAP1 is an attractive target for antibody-based therapy or immunotherapy. However, its role in modulating the pathophysiology of colorectal cancer (CRC) remains relatively unexplored. In this study, we first demonstrated that the STEAP1 transcript level was significantly higher in CRC tissues than in normal colonic tissues. Of note, STEAP1 expression negatively correlated with overall survival as determined from a publicly accessible gene expression profile data set. A loss-of-function approach in cultured CRC cell lines revealed that STEAP1 silencing suppressed cell growth and increased reactive oxygen species (ROS) production, followed by apoptosis, through an intrinsic pathway. Mechanistically, the inhibition of STEAP1 was associated with decreased expression of antioxidant molecules regulated by the transcription factor, nuclear erythroid 2-related factor (NRF2), in CRC cells. Taken together, we identified high STEAP1 transcript levels leading to reduced ROS production that prevented apoptosis via the NRF2 pathway in CRC cells as a pathological mechanism in CRC. This study highlights the STEAP1-NRF2 axis as a therapeutic target for CRC and its manipulation as a novel strategy to conquer CRC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Knockdown analysis of STEAP1 using small interfering (si)RNA revealed that it regulates ROS levels by manipulating NRF2 and downstream genes in colorectal cancer cells (Figure 2).18”
From Reactive Oxygen Species in Cancer: Current Findings and Future Directions (2021) · cites this paper as [18]
In the citing paper
“Specifically, we have previously reported that the six‐transmembrane epithelial antigen of the prostate1 (STEAP1), which was identified as a cell surface protein and works as an intracellular transporter, is overexpressed in colorectal cancer cells compared with normal counterparts.”
From Reactive Oxygen Species in Cancer: Current Findings and Future Directions (2021) · cites this paper as [18]
In the citing paper
“We have previously reported that the suppression of cell growth accompanied by apoptosis was evoked through increased intracellular ROS levels in MM and colorectal cancer cells.17, 18”
From Reactive Oxygen Species in Cancer: Current Findings and Future Directions (2021) · cites this paper as [18]
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
Kanda, Y. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2012.244 · Cited by 18,767
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw235 · Cited by 3,421
Brenner, H., Kloor, M., & Pox, C. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61649-9 · Cited by 2,762
Physiological Roles of Mitochondrial Reactive Oxygen Species
Sena, L. A., & Chandel, N. S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.025 · Cited by 2,632
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
Hayes, J. D., & Dinkova-Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,141
Nrf2–Keap1 defines a physiologically important stress response mechanism
Motohashi, H., & Yamamoto, M. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.003 · Cited by 1,725
NRF2 and cancer: the good, the bad and the importance of context
Sporn, M. B., & Liby, K. T. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3278 · Cited by 1,067
Cited by
Reactive Oxygen Species in Cancer: Current Findings and Future Directions
Nakamura, H., & Takada, K. (2021) · Cancer Science · doi:10.1111/cas.15068 · Cited by 1,027
Self-citationGuo, Q., Ke, X., Liu, Z., Gao, W., Fang, S., Chen, C., Song, Y., Han, H., Lu, H., & Xu, G. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00242 · Cited by 44
Chen, W.-J., Wu, H.-T., Li, C., Lin, Y.-K., Fang, Z.-X., Lin, W., & Liu, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.752426 · Cited by 44
Yang, Q. Z., Ji, G., & Li, J. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1685290 · Cited by 31
Jiao, Z., Huang, L., Sun, J., Xie, J., Wang, T., Yin, X. R., Zhang, H., & Chen, J. (2020) · Histochemistry and Cell Biology · doi:10.1007/s00418-020-01877-7 · Cited by 31
Metadata
- Authors
- Nakamura, H., Takada, K., Arihara, Y., Hayasaka, N., Murase, K., Iyama, S., Kobune, M., Miyanishi, K., & Kato, J.
- Affiliations
- Sapporo Medical University (JP)
- Corresponding author
- Miyanishi, Koji
- ORCID
- Venue
- Cancer Gene Therapy
- Published
- 2018-11-07
- Volume
- 26
- Issue
- 9-10
- Pages
- 313-322
- ISSN
- 0929-1903 (ISSN-L)
- 1476-5500
- OpenAlex
- W2899519291
- Cited by
- 29
- References
- 29
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 1 · 2021: 5 · 2020: 2 · 2019: 2
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cancer Gene Therapy (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (16K07178)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- STEAP1, colorectal cancer, Nrf2, oxidative stress, reactive oxygen species, apoptosis, antioxidant genes, prognostic factors, therapeutic target, gene silencing
- MeSH terms
- Antigens, Neoplasm, Humans, Oxidoreductases, Prognosis, Colorectal Neoplasms, Signal Transduction, Apoptosis, Reactive Oxygen Species, Oxidative Stress, Gene Silencing, Gene Expression Profiling, Databases, Genetic, RNA, Small Interfering, Cell Line, Tumor, NF-E2-Related Factor 2, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Six-transmembrane epithelial antigen of the prostate 1 protects against increased oxidative stress via a nuclear erythroid 2-related factor pathway in colorectal cancer. https://app.cochat.ai/papers/10.1038/s41417-018-0056-8
- The paper
- Nakamura, H., Takada, K., Arihara, Y., Hayasaka, N., Murase, K., Iyama, S., Kobune, M., Miyanishi, K., & Kato, J. (2019). Six-transmembrane epithelial antigen of the prostate 1 protects against increased oxidative stress via a nuclear erythroid 2-related factor pathway in colorectal cancer. Cancer Gene Therapy. https://doi.org/10.1038/s41417-018-0056-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.